Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

T Cell Stimulatory Effects of Korean Red Ginseng through Modulation of Myeloid-Derived Suppressor Cells

  • Received : 2011.08.29
  • Accepted : 2011.10.01
  • Published : 2011.12.26
Download PDF
⟨ Previous Next ⟩

Abstract

Myeloid-derived suppressor cells (MDSCs) actively suppress immune cells and have been considered as an impediment to successful cancer immunotherapy. Many approaches have been made to overcome such immunosuppressive factors and to exert effective anti-tumor effects, but the possibility of using medicinal plants for this purpose has been overlooked. Korean red ginseng (KRG) is widely known to possess a variety of pharmacological properties, including immunoboosting and anti-tumor activities. However, little has been done to assess the anti-tumor activity of KRG on MDSCs. Therefore, we examined the effects of KRG on MDSCs in tumor-bearing mice and evaluated immunostimulatory and anti-tumor activities of KRG through MDSC modulation. The data show that intraperitoneal administration of KRG compromises MDSC function and induces T cell proliferation and the secretion of IL-2 and IFN-${\gamma}$, while it does not exhibit direct cytotoxicity on tumor cells and reduced MDSC accumulation. MDSCs isolated from KRG-treated mice also express significantly lower levels of inducible nitric oxide synthase and IL-10 accompanied by a decrease in nitric oxide production compared with control. Taken together, the present study demonstrates that KRG enhances T cell function by inhibiting the immunosuppressive activity of MDSCs and suggests that although KRG alone does not exhibit direct anti-tumor effects, the use of KRG together with conventional chemo- or immunotherapy may provide better outcomes to cancer patients through MDSC modulation.

Keywords

References

  1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174. https://doi.org/10.1038/nri2506
  2. Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008;222:162-179. https://doi.org/10.1111/j.1600-065X.2008.00602.x
  3. Haile LA, von Wasielewski R, Gamrekelashvili J, Kruger C, Bachmann O, Westendorf AM, Buer J, Liblau R, Manns MP, Korangy F et al. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 2008;135:871-881, 881.e1-5. https://doi.org/10.1053/j.gastro.2008.06.032
  4. Angulo I, de las Heras FG, Garcia-Bustos JF, Gargallo D, Munoz-Fernandez MA, Fresno M. Nitric oxide-producing $CD11b^+Ly-6G(Gr-1)^+CD31(ER-MP12)^+$ cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 2000;95:212-220.
  5. Zhu B, Bando Y, Xiao S, Yang K, Anderson AC, Kuchroo VK, Khoury SJ. $CD11b^+Ly-6^{Chi}$ suppressive monocytes in experimental autoimmune encephalomyelitis. J Immunol 2007;179:5228-5237. https://doi.org/10.4049/jimmunol.179.8.5228
  6. Nagaraj S, Collazo M, Corzo CA, Youn JI, Ortiz M, Quiceno D, Gabrilovich DI. Regulatory myeloid suppressor cells in health and disease. Cancer Res 2009;69:7503-7506. https://doi.org/10.1158/0008-5472.CAN-09-2152
  7. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of $CD8^+$ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004;172:989-999. https://doi.org/10.4049/jimmunol.172.2.989
  8. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181:5791-5802. https://doi.org/10.4049/jimmunol.181.8.5791
  9. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111:4233-4244. https://doi.org/10.1182/blood-2007-07-099226
  10. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5:641-654. https://doi.org/10.1038/nri1668
  11. Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008;222:180-191. https://doi.org/10.1111/j.1600-065X.2008.00608.x
  12. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998;160:5729-5734.
  13. Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002;168:689-695. https://doi.org/10.4049/jimmunol.168.2.689
  14. Farrer DG, Hueber S, Laiosa MD, Eckles KG, McCabe MJ Jr. Reduction of myeloid suppressor cell derived nitric oxide provides a mechanistic basis of lead enhancement of alloreactive $CD4^+$ T cell proliferation. Toxicol Appl Pharmacol 2008;229:135-145. https://doi.org/10.1016/j.taap.2007.12.011
  15. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients. Cancer Res 2001;61:4756-4760.
  16. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006;5:14. https://doi.org/10.1186/1477-3163-5-14
  17. Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, Lush RM, Antonia S, Gabrilovich DI. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res 2006;66:9299-9307. https://doi.org/10.1158/0008-5472.CAN-06-1690
  18. Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, Dolcetti L, Bronte V, Borrello I. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J Exp Med 2006;203:2691-2702. https://doi.org/10.1084/jem.20061104
  19. De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, Del Soldato P, Melani C, Guiducci C, Colombo MP, Iezzi M et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc Natl Acad Sci U S A 2005;102:4185-4190. https://doi.org/10.1073/pnas.0409783102
  20. Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. Gemcitabine selectively eliminates splenic $Gr-1^+/CD11b^+$ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 2005;11:6713-6721. https://doi.org/10.1158/1078-0432.CCR-05-0883
  21. Yun TK. Brief introduction of Panax ginseng C.A. Meyer. J Korean Med Sci 2001;16 Suppl:S3-S5. https://doi.org/10.3346/jkms.2001.16.S.S3
  22. Jin SH, Park JK, Nam KY, Park SN, Jung NP. Korean red ginseng saponins with low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced learning disability and spatial working memory in mice. J Ethnopharmacol 1999;66:123-129. https://doi.org/10.1016/S0378-8741(98)00190-1
  23. Jeon BH, Kim CS, Kim HS, Park JB, Nam KY, Chang SJ. Effect of Korean red ginseng on blood pressure and nitric oxide production. Acta Pharmacol Sin 2000;21:1095-1100.
  24. Surh YJ, Ferguson LR. Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventive potential-highlights of a symposium. Mutat Res 2003;523-524:1-8. https://doi.org/10.1016/S0027-5107(02)00343-3
  25. Kaneko H, Nakanishi K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, Korean red ginseng: specifically, its anti-stress action for prevention of disease. J Pharmacol Sci 2004;95:158-162. https://doi.org/10.1254/jphs.FMJ04001X5
  26. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46-56. https://doi.org/10.1016/j.numecd.2006.04.003
  27. Choi HS, Kim KH, Sohn E, Park JD, Kim BO, Moon EY, Rhee DK, Pyo S. Red ginseng acidic polysaccharide (RGAP) in combination with IFN-gamma results in enhanced macrophage function through activation of the NF-kappaB pathway. Biosci Biotechnol Biochem 2008;72:1817-1825. https://doi.org/10.1271/bbb.80085
  28. Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M. An open-label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer's disease. Eur J Neurol 2008;15:865-868. https://doi.org/10.1111/j.1468-1331.2008.02157.x
  29. Yun TK, Zheng S, Choi SY, Cai SR, Lee YS, Liu XY, Cho KJ, Park KY. Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers. J Med Food 2010;13:489-494. https://doi.org/10.1089/jmf.2009.1275
  30. Cho SH, Chung KS, Choi JH, Kim DH, Lee KT. Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells. BMC Cancer 2009;9:449. https://doi.org/10.1186/1471-2407-9-449
  31. Choi CH, Kang G, Min YD. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng. Planta Med 2003;69:235-240. https://doi.org/10.1055/s-2003-38483
  32. Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, Son WS, Kim GY, Choi YH, Kim ND. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol 2009;121:304-312. https://doi.org/10.1016/j.jep.2008.10.038
  33. Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside $Rg_3$. Biochem Pharmacol 2003;65:75-82. https://doi.org/10.1016/S0006-2952(02)01446-6
  34. Yoon SR, Lee GD, Park JH, Lee IS, Kwon JH. Ginsenoside composition and antiproliferative activities of explosively puffed ginseng (Panax ginseng C.A. Meyer). J Food Sci 2010;75:C378-C382. https://doi.org/10.1111/j.1750-3841.2010.01592.x
  35. He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD, Xu H. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol 2010;184:2281-2288. https://doi.org/10.4049/jimmunol.0902574
  36. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009;182:4499-4506. https://doi.org/10.4049/jimmunol.0802740
  37. Kim YJ, Kwon HC, Ko H, Park JH, Kim HY, Yoo JH, Yang HO. Anti-tumor activity of the ginsenoside $Rk_1$ in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biol Pharm Bull 2008;31:826-830. https://doi.org/10.1248/bpb.31.826
  38. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011;301:185-192. https://doi.org/10.1016/j.canlet.2010.11.015
  39. Kumar A, Kumar M, Park TY, Park MH, Takemoto T, Terado T, Kitano M, Kimura H. Molecular mechanisms of ginsenoside $Rp_1$-mediated growth arrest and apoptosis. Int J Mol Med 2009;24:381-386.
  40. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-2975. https://doi.org/10.1002/eji.201040895
  41. Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007;13:828-835. https://doi.org/10.1038/nm1609
  42. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 2010;40:22-35.

Cited by

  1. Antitumor Immunity and Dietary Compounds vol.2, pp.1, 2013, https://doi.org/10.3390/medsci2010001
  2. B and AP-1 activity vol.36, pp.5, 2014, https://doi.org/10.3109/08923973.2014.947036
  3. Identification of aminosulfonylarylisoxazole as microRNA-31 regulators vol.12, pp.8, 2017, https://doi.org/10.1371/journal.pone.0182331
  4. Regulation of the viral life cycle by murine gammaherpesvirus 68 microRNAs vol.162, pp.3, 2017, https://doi.org/10.1007/s00705-016-3150-y
  5. Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration vol.15, pp.1, 2015, https://doi.org/10.1186/s12906-015-0649-9
  6. Estrogen Receptor Is Activated by Korean Red Ginseng In Vitro but Not In Vivo vol.36, pp.2, 2011, https://doi.org/10.5142/jgr.2012.36.2.169
  7. Methanol extract of Osbeckia stellata suppresses lipopolysaccharide- and HCl/ethanol-induced inflammatory responses by inhibiting Src/Syk and IRAK1 vol.143, pp.3, 2011, https://doi.org/10.1016/j.jep.2012.08.015
  8. Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus vol.41, pp.4, 2017, https://doi.org/10.1016/j.jgr.2016.08.010
  9. Bioactive Proteins in Panax notoginseng Roots and Other Panax Species vol.20, pp.3, 2011, https://doi.org/10.2174/1389203719666180612083650
  10. Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment vol.18, pp.None, 2019, https://doi.org/10.1177/1534735419886655
  11. Sources, Extraction and Biomedical Properties of Polysaccharides vol.8, pp.8, 2011, https://doi.org/10.3390/foods8080304
  12. Modulation of Immunosuppression by Oligonucleotide-Based Molecules and Small Molecules Targeting Myeloid-Derived Suppressor Cells vol.28, pp.1, 2011, https://doi.org/10.4062/biomolther.2019.069
  13. Inhibitory effect of ginsenoside Rg3 on cancer stemness and mesenchymal transition in breast cancer via regulation of myeloid-derived suppressor cells vol.15, pp.10, 2011, https://doi.org/10.1371/journal.pone.0240533
  14. Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment vol.9, pp.None, 2011, https://doi.org/10.3389/fcell.2021.635122